A citation-based method for searching scientific literature

Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
Times Cited: 64



Per Svenningsson, Karin Wirdefeldt, Li Yin, Fang Fang, Ioanna Markaki, Suad Efendic, Jonas F Ludvigsson. Mov Disord 2016
Times Cited: 41




List of shared articles



Times cited

Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging.
Grazyna Lietzau, Giulia Magni, Jan Kehr, Takashi Yoshitake, Emanuel Candeias, Ana I Duarte, Hans Pettersson, Josefin Skogsberg, Maria P Abbracchio, Thomas Klein,[...]. Neurobiol Aging 2020
8

Does glitazone treatment have a role on the prevention of Parkinson's disease in adult diabetic population? A systematic review.
Jesús D Meléndez-Flores, Juan Manuel Millán-Alanís, Adrián González-Martínez, Neri Alejandro Álvarez-Villalobos, Ingrid Estrada-Bellmann. Metab Brain Dis 2020
3

Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Xiaocui Qin, Xia Zhang, Pinyu Li, Min Wang, Li Yan, Zeqing Bao, Qili Liu. Front Neurol 2021
7

Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Ruth Brauer, Li Wei, Tiantian Ma, Dilan Athauda, Christine Girges, Nirosen Vijiaratnam, Grace Auld, Cate Whittlesea, Ian Wong, Tom Foltynie. Brain 2020
43

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
1

Old wines in new bottles: Repurposing opportunities for Parkinson's disease.
Ashish Kumar Kakkar, Harmanjit Singh, Bikash Medhi. Eur J Pharmacol 2018
11



Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson's Disease.
Yilin Tang, Ke Yang, Jue Zhao, Xiaoniu Liang, Jian Wang. ACS Chem Neurosci 2019
2

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
5

Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
23